Oxetanes as Versatile Elements in Drug Discovery and Synthesis

被引:348
作者
Burkhard, Johannes A. [1 ]
Wuitschik, Georg [1 ]
Rogers-Evans, Mark [2 ]
Mueller, Klaus [2 ]
Carreira, Erick M. [1 ]
机构
[1] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland
[2] F Hoffmann La Roche & Cie AG, Div Pharmaceut, CH-4070 Basel, Switzerland
关键词
drug discovery; heterocyclic compounds; oxetanes; spiro compounds; HYDROGEN-BOND BASICITY; HUMAN-IMMUNODEFICIENCY-VIRUS; ASYMMETRIC RING EXPANSION; PARTIAL MOLAR VOLUMES; TRIMETHYLENE OXIDE; 2,2-DISUBSTITUTED OXETANES; BIOLOGICAL EVALUATION; RENIN INHIBITORS; DICTYOTA-DICHOTOMA; ORGANIC-COMPOUNDS;
D O I
10.1002/anie.200907155
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Sizable resources, both financial and human, are invested each year in the development of new pharmaceutical agents. However, despite improved techniques, the new compounds often encounter difficulties in satisfying and overcoming the numerous physicochemical and many pharmacological constraints and hurdles. Oxetanes have been shown to improve key properties when grafted onto molecular scaffolds. Of particular interest are oxetanes that are substituted only in the 3-position, since such units remain achiral and their introduction into a molecular scaffold does not create a new stereocenter. This Minireview gives an overview of the recent advances made in the preparation and use of 3-substituted oxetanes. It also includes a discussion of the site-dependent modifications of various physicochemical and biochemical properties that result from the incorporation of the oxetane unit in molecular architectures. Small but powerful: In recent years oxetanes have received newly gained attention in medicinal chemistry and by the synthetic community since it has been found that the introduction of an oxetane unit in the molecular scaffold of a compound can significantly modify its properties. This Minireview summarizes the advantages of oxetanes in drug discovery and outlines chemical transformations involving oxetanes. Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:9052 / 9067
页数:16
相关论文
共 144 条
[1]   PENTAERYTHRITOL DERIVATIVES .5. PREPARATION OF DIETHERS OF PENTAERYTHRITOL BY REDUCTION OF ACETALS AND KETALS [J].
ABDUNNUR, AR ;
ISSIDORIDES, CH .
JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (01) :67-&
[2]   Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1 [J].
Ahmad, S ;
Doweyko, LM ;
Dugar, S ;
Grazier, N ;
Ngu, K ;
Wu, SC ;
Yost, KJ ;
Chen, BC ;
Gougoutas, JZ ;
DiMarco, JD ;
Lan, SJ ;
Gavin, BJ ;
Chen, AY ;
Dorso, CR ;
Serafino, R ;
Kirby, M ;
Atwal, KS .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (20) :3302-3310
[3]  
ALBERT R, 2009, Patent No. 2009068682
[4]   ROLE OF SUBSTRATE LIPOPHILICITY IN DETERMINING TYPE-1 MICROSOMAL P450 BINDING CHARACTERISTICS [J].
ALGAILANY, KAS ;
HOUSTON, JB ;
BRIDGES, JW .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (05) :783-788
[5]  
[Anonymous], 2010, ANGEW CHEM
[6]   1,3-allylic strain as a control element in the Paterno-Buchi reaction of chiral silyl enol ethers: Synthesis of diastereomerically pure oxetanes containing four contiguous stereogenic centers [J].
Bach, T ;
Jodicke, K ;
Kather, K ;
Frohlich, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (10) :2437-2445
[7]   Synthesis of five-, six-, and seven-membered heterocycles by intramolecular ring opening reactions of 3-oxetanol derivatives [J].
Bach, T ;
Kather, K ;
Krämer, O .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (06) :1910-1918
[8]  
Bach T, 1998, SYNTHESIS-STUTTGART, P683
[9]   FACIAL DIASTEREOSELECTIVITY IN THE PATERNO-BUCHI REACTION OF CHIRAL SILYL ENOL ETHERS [J].
Bach, T ;
Jodicke, K ;
Kather, K ;
Hecht, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1995, 34 (20) :2271-2273
[10]  
BACH T, 1995, ANGEW CHEM, V107, P2455